Paper
21 May 2001 Carbon dioxide reactivity of tumor blood flow as measured by dynamic contrast-enhanced computed tomography: a new treatment protocol for laser thermal therapy
Thomas G. Purdie, Michael D. Sherar, Aaron Fenster, Ting-Yim Lee
Author Affiliations +
Abstract
The purpose of the current study is to measure the carbon dioxide reactivity of blood flow in VX2 tumor in the rabbit thigh. The carbon dioxide reactivity of the functional parameters was investigated in eight rabbits by changing the ventilation rate in order to manipulate the arterial carbon dioxide tension (PaCO2). In each experiment, functional maps were generated at four PaCO2 levels: normocapnia (PaCO2 equals 40.7 +/- 1.4 mm Hg), hypocapnia (27.1 +/- 2.5 and 33.7 +/- 2.2) and hypercapnia (53.8 +/- 5.2). The carbon dioxide reactivity of tumor blood flow showed significant differences between normocapnia and the two levels of hypocapnia, but not between normocapnia and hypercapnia. The average fractional change of blood flow from normocapnia for the two hypocapnic level was -0.41 +/- 0.06 and -0.29 +/- 0.08, respectively. The ability to reduce blood flow through hypocapnia has significant implications in thermal therapy, as heat dissipation represents a major obstacle which limits the effectiveness of treatment.
© (2001) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Thomas G. Purdie, Michael D. Sherar, Aaron Fenster, and Ting-Yim Lee "Carbon dioxide reactivity of tumor blood flow as measured by dynamic contrast-enhanced computed tomography: a new treatment protocol for laser thermal therapy", Proc. SPIE 4321, Medical Imaging 2001: Physiology and Function from Multidimensional Images, (21 May 2001); https://doi.org/10.1117/12.428122
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Blood circulation

Tumors

Tissues

Computed tomography

Mercury

Laser therapeutics

Arteries

Back to Top